Codexis, Inc.

Healthcare

NASDAQ:CDXS · NASDAQ Global Select

Market Cap $220.42M Beta 2.48 P/E (TTM) -7.1

$2.57 +0.60%

+$0.02 today

52W Low $0.96High $3.87

Vol 1.73M · Avg 1.15M

EPS (TTM) -$0.35Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+8.90%

Period High

$3.33

Period Low

$0.98

Latest

$2.57

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Genfit S.A.

GNFT

$445.68M

C4 Therapeutics, Inc.

NASDAQ:CCCC

$332.09M

OmniAb, Inc.

NASDAQ:OABI

$260.21M

Armata Pharmaceuticals, Inc.

AMEX:ARMP

$258.44M

Innate Pharma S.A.

NASDAQ:IPHA

$169.96M

Protara Therapeutics, Inc.

NASDAQ:TARA

$155.32M

Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

$145.21M

Invivyd, Inc.

NASDAQ:IVVD

$127.77M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$71.28M

Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

$50.73M

What is the latest CDXS filing?

The latest filing shown is 4 dated Jun 11, 2026.

How many recent filings does CDXS have?

Intrinsic Alpha currently shows 20 recent filings for CDXS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.